tiprankstipranks
Trending News
More News >
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Ratios

Compare
1,281 Followers

Entero Therapeutics Ratios

ENTO's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, ENTO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.37 1.58 1.37 0.77 0.51
Quick Ratio
0.59 1.58 0.59 0.77 0.43
Cash Ratio
0.55 1.18 0.55 0.67 0.39
Solvency Ratio
-5.41 -4.81 -5.41 -2.96 -2.06
Operating Cash Flow Ratio
-9.00 -3.95 -9.00 -2.62 -0.72
Short-Term Operating Cash Flow Coverage
-37.02 -20.20 -37.02 -50.35 -20.31
Net Current Asset Value
$ 715.21K$ 1.68M$ 715.21K$ -10.19M$ -7.69M
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.12 0.16 0.09 0.05
Debt-to-Equity Ratio
0.32 0.23 0.32 -0.13 -0.24
Debt-to-Capital Ratio
0.24 0.19 0.24 -0.15 -0.31
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.98 1.91 1.98 -1.51 -4.89
Debt Service Coverage Ratio
-23.63 -24.78 -23.63 -129.52 -6.47
Interest Coverage Ratio
-798.42 -702.08 -798.42 -5.26K -4.53
Debt to Market Cap
0.14 0.48 0.14 0.05 0.02
Interest Debt Per Share
25.05 2.53 25.05 490.12 9.56K
Net Debt to EBITDA
0.03 0.18 0.03 0.12 0.21
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
115.39%100.15%115.39%99.12%123.60%
Return on Assets (ROA)
-268.94%-229.47%-268.94%-496.51%-252.80%
Return on Equity (ROE)
-533.51%-438.39%-533.51%748.42%1237.23%
Return on Capital Employed (ROCE)
-428.86%-420.57%-428.86%11570.43%1008.28%
Return on Invested Capital (ROIC)
-352.68%-356.02%-352.68%-41095.68%1921.70%
Return on Tangible Assets
-389.55%-303.81%-389.55%-592.59%-408.89%
Earnings Yield
-332.17%-1229.35%-332.17%-453.86%-118.45%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.15 0.05 0.15 0.20 0.37
Inventory Turnover
0.05 0.00 0.05 0.00 0.46
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
4.24K -6.91K 4.24K -1.84K -194.43
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
6.72K 0.00 6.72K 0.00 801.61
Days of Payables Outstanding
2.47K 6.91K 2.47K 1.84K 996.04
Operating Cycle
6.72K 0.00 6.72K 0.00 801.61
Cash Flow Ratios
Operating Cash Flow Per Share
-622.19 -36.80 -622.19 -15.19K -16.57K
Free Cash Flow Per Share
-622.19 -38.29 -622.19 -20.05K -16.58K
CapEx Per Share
0.00 1.49 0.00 4.86K 6.15
Free Cash Flow to Operating Cash Flow
1.00 1.04 1.00 1.32 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -24.76 0.00 -3.13 -2.69K
Capital Expenditure Coverage Ratio
0.00 -24.76 0.00 -3.13 -2.69K
Operating Cash Flow Coverage Ratio
-25.28 -14.97 -25.28 -31.34 -17.84
Operating Cash Flow to Sales Ratio
0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-507.33%-1002.30%-507.33%-330.35%-40.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.30 -0.08 -0.30 -0.22 -0.84
Price-to-Sales (P/S) Ratio
0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
1.61 0.36 1.61 -1.65 -10.45
Price-to-Free Cash Flow (P/FCF) Ratio
-0.20 -0.10 -0.20 -0.30 -2.46
Price-to-Operating Cash Flow Ratio
-0.20 -0.10 -0.20 -0.40 -2.46
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
1.61 0.36 1.61 -1.65 -10.45
Enterprise Value Multiple
-0.27 0.10 -0.27 -0.10 -0.84
Enterprise Value
3.93M -1.60M 3.93M 5.68M 22.15M
EV to EBITDA
-0.27 0.10 -0.27 -0.10 -0.84
EV to Sales
0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
-0.18 0.12 -0.18 -0.13 -1.97
EV to Operating Cash Flow
-0.18 0.13 -0.18 -0.18 -1.97
Tangible Book Value Per Share
29.46 5.70 29.46 -4.58K -11.19K
Shareholders’ Equity Per Share
76.36 10.71 76.36 -3.68K -3.90K
Tax and Other Ratios
Effective Tax Rate
>-0.01 0.00 >-0.01 -0.45 -0.46
Revenue Per Share
0.00 0.00 0.00 0.00 0.00
Net Income Per Share
-407.37 -46.96 -407.37 -27.54K -48.26K
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 1.00 1.00 1.00 1.22
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.53 0.78 1.53 0.55 0.34
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis